In vitro antibacterial activity of prulifloxacin, a new oral fluoroquinolone

Japanese Journal of Antibiotics

Volumn 55, Issue 6, 2002, Pages 778-790

  Minako Araake, ^a   Tetsuro Hara, ^a   Watabe, Hiroomi ^a   Nishino, Takeshi ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

6 FLUORO 1 METHYL 4 OXO 7 (1 PIPERAZINYL) 4H 1,3 THIAZETO[3,2 A]QUINOLINE 3 CARBOXYLIC ACID; CIPROFLOXACIN; DRUG METABOLITE; FLEROXACIN; GATIFLOXACIN; LEVOFLOXACIN; PRODRUG; PRULIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOSUFLOXACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MAXIMUM ALLOWABLE CONCENTRATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA; SERRATIA MARCESCENS; STREPTOCOCCUS PNEUMONIAE;

EID: 0036952196     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. YOSHIDA, T. & S. MITSUHASHI: Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone. Antimicrob. Agents Chemother. 37: 794-800, 1993
2. Jpn. J. Antibiotics 53: 593-608, 2000
3. Chemotherapy 29: 76-79, 1981